Skip to main content
NCBI home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 1998 Sep 1;75(3):584–599. doi: 10.1007/BF02427705

Active immunization against poliomyelitis

Herald R Cox 1
PMCID: PMC5587435  PMID: 9762651

Full Text

The Full Text of this article is available as a PDF (960.2 KB).

Footnotes

Presented at the Stated Meeting of The New York Academy of Medicine in the Symposium on Poliomyelitis: Its Control and Prevention, April 2, 1953; manuscript received June 1953

References

  • 1.Cox HR. Viral vaccines and human welfare. Lancet. 1953;265:1–5. doi: 10.1016/S0140-6736(53)90001-4. [DOI] [PubMed] [Google Scholar]
  • 2.Morgan IM. Immunization of monkeys with formalin-inactivated poliomyelitis viruses. Am J Hug. 1948;48:394–406. doi: 10.1093/oxfordjournals.aje.a119251. [DOI] [PubMed] [Google Scholar]
  • 3.Howe HA. Antibody response of chimpanzees and human beings to formalin-inactivated trivalent poliomyelitis vaccine. Am J Hyg. 1952;56:265–286. doi: 10.1093/oxfordjournals.aje.a119551. [DOI] [PubMed] [Google Scholar]
  • 4.Koprowski H, Cox HR. Studies on chick embryo adapted rabies virus; culture characteristics and pathogenicity. J Immunol. 1948;60:533–554. [PubMed] [Google Scholar]
  • 5.Koprowski H. Experimental studies on rabies virus. Can J Public Health. 1949;40:60–67. [PubMed] [Google Scholar]
  • 6.Cox HR. Review of chick-embryo adapted living rabies virus vaccines, with primary emphasis on use in dogs. Proc. US Live Stock Sanit Assoc. 1949;53:264–272. [Google Scholar]
  • 7.Koprowski H, Black J. Studies on chick-embryo adapted rabies virus; pathogenicity for dogs and use of egg-adapted strains for vaccination purposes. J Immunol. 1950;64:185–196. [PubMed] [Google Scholar]
  • 8.Koprowski H. Immunization with modified living vvirus with particular reference to rabies and hog cholera. Vet Med. 1952;47:144–150. [Google Scholar]
  • 9.Koprowski H, Black J. Studies on chick embryo adapted rabies virus; duration of immunity in vaccinated dogs. Proc Soc Exp Biol Med. 1952;80:410–415. doi: 10.3181/00379727-80-19640. [DOI] [PubMed] [Google Scholar]
  • 10.Schroeder CR, Black J, Burkhart RL, Koprowski H. Rabies in cattle; prevention of vampire bat paralytic rabies, derriengue, by vaccination with chick-embryo-adapted rabies virus. Vet Med. 1952;47:502–506. [Google Scholar]
  • 11.Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science. 1949;109:85–87. doi: 10.1126/science.109.2822.85. [DOI] [PubMed] [Google Scholar]
  • 12.Weller TH, Robbins FC, Enders JF. Cultivation of poliomyelitis virus in cultures of human foreskin and embryonic tissues. Proc Soc Exp Biol Med. 1949;72:153–155. doi: 10.3181/00379727-72-17359. [DOI] [PubMed] [Google Scholar]
  • 13.Robbins FC, Enders JF, Weller TH. The effect of poliomyelitis virus upon cells in tissue cultures [abstract] J Clin Invest. 1950;29:841–841. [PubMed] [Google Scholar]
  • 14.Robbins FC, Enders JF, Weller TH, Florentino GL. Studies on the cultivation of poliomyelitis viruses in tissue culture; the direct isolation and serologic identification of virus strains in tissue culture from patients with nonparalytic and paralytic poliomyelitis. Am J Hug. 1951;54:286–293. doi: 10.1093/oxfordjournals.aje.a119486. [DOI] [PubMed] [Google Scholar]
  • 15.Enders JF. General preface to studies on the cultivation of poliomyelitis viruses in tissue cultures. J Immunol. 1952;69:639–643. [PubMed] [Google Scholar]
  • 16.Weller TH, Enders JF, Robbins FC, Stoddard MB. Studies on the cultivation of poliomyelitys viruses in tissue culture; the propagation of poliomyelitis viruses in suspended cell cultures of various human tissues. J Immunol. 1952;69:645–671. [PubMed] [Google Scholar]
  • 17.Robbins FC, Weller TH, Enders JF. Studies on the cultivation of poliomyelitis viruses in tissue culture; the propagation of the poliomyelitis viruses in roller-tube cultures of various human tissues. J Immunol. 1952;69:673–694. [PubMed] [Google Scholar]
  • 18.Svedmyr A, Enders JF, Holloway A. Complement fixation with Brunhilde and Lansing poliomyelitis viruses propagated in tissue culture. Proc Soc Exp Biol Med. 1952;79:296–300. doi: 10.3181/00379727-79-19357. [DOI] [PubMed] [Google Scholar]
  • 19.Svedmyr A, Enders JF, Holloway A. Complement fixation with the three types of poliomyelitis viruses propagated in tissue culture. Am J Hug. 1953;57:60–70. doi: 10.1093/oxfordjournals.aje.a119563. [DOI] [PubMed] [Google Scholar]
  • 20.Youngner JS, Ward EN, Salk JE. Studies on poliomyelitis viruses in cultures of monkey testicular tissue; propagation of virus in roller tubes. Am J Hug. 1952;55:291–300. doi: 10.1093/oxfordjournals.aje.a119522. [DOI] [PubMed] [Google Scholar]
  • 21.Younger JS, Ward EN, Salk JE. Studies on poliomyelitis viruses in cultures of monkey testicular tissue; differences among strains in tissue culture infectivity with preliminary data on the quantitative estimation of virus and antibody. Am J Hug. 1952;55:301–322. [PubMed] [Google Scholar]
  • 22.Younger JS, Lewis LJ, Ward EN, Salk JE. Studies on poliomyelitis viruses in cultures of monkey testicular tissue; isolation and immunologic identification of poliomyelitis viruses from fecal specimens by means of roller tube cultures. Am J Hug. 1952;55:347–356. [PubMed] [Google Scholar]
  • 23.Ledinko N, Riordan JT, Melnick JL. Differences in cellular pathogenicity of two immunologically related poliomyelitis viruses as revealed in tissue culture. Proc Soc Exp Biol Med. 1951;78:83–88. doi: 10.3181/00379727-78-18982. [DOI] [PubMed] [Google Scholar]
  • 24.Ledinko N, Melnick JL. Poliomyelitis viruses in tissue culture; susceptibility of testicular tissue from immune monkeys. Proc Soc Exp Biol Med. 1952;81:144–148. doi: 10.3181/00379727-81-19805. [DOI] [PubMed] [Google Scholar]
  • 25.Melnick JL, Riordan JT. Poliomyelitis viruses in tissue culture; protein-free nutrient media in stationary and roller tube cultures. Proc Soc Exp Biol Med. 1952;81:208–213. doi: 10.3181/00379727-81-19823. [DOI] [PubMed] [Google Scholar]
  • 26.Ledinko N, Riordan JT, Melnick JL. Multiplication of poliomyelitis viruses in tissue cultures of monkey testes; growth curves of Type 1 (Brunhilde) and Type 2 (Lansing) strains and description of a quantitative neutralization test. Am J Hug. 1952;55:323–338. doi: 10.1093/oxfordjournals.aje.a119524. [DOI] [PubMed] [Google Scholar]
  • 27.Riordan JT, Ledinko N, Melnick JL. Multiplication of poliomyelitis viruses in tissue cultures of monkey testes; direct isolation and typing of strains from human stools and spinal cords in roller tubes. Am J Hug. 1952;55:339–346. doi: 10.1093/oxfordjournals.aje.a119525. [DOI] [PubMed] [Google Scholar]
  • 28.Syverton JT, Scherer WF, Butorac G. Propagation of poliomyelitis virus in cultures of monkey and human testicular tissues. Proc Soc Exp Biol Med. 1951;77:23–28. doi: 10.3181/00379727-77-18665. [DOI] [PubMed] [Google Scholar]
  • 29.Syverton JT, Scherer WF. Studies on the propagationin vitro of poliomyelitis viruses; viral multiplication in tissue cultures employing monkey and human testicular cells. J Exp Med. 1952;96:355–367. doi: 10.1084/jem.96.4.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Scherer WF, Syverton JT. Studies on the propagationin vitro of poliomyelitis viruses; a description of the growth curve and its relation to the cytopathogenicity of poliomyelitis virus. J Exp Med. 1952;96:369–388. doi: 10.1084/jem.96.4.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Scherer WF, Syverton JT. Studies on the propagationin vitro of poliomyelitis viruses; the propagation of poliomyelitis viruses in tissue cultures devoid of nerve cells. J Exp Med. 1952;96:389–400. doi: 10.1084/jem.96.4.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Scherer WF, Syverton JT, Gey GO. Studies on the propagationin vitro of poliomyelitis viruses; viral multiplication in a stable strain of human malignant epithelial cells (strain Héla) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695–710. doi: 10.1084/jem.97.5.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Franklin AE, Duncan D, Wood W, Rhodes AJ. Cultivation of Lansing poliomyelitis virus in tissue culture; utilization of glucose in synthetic medium. Proc Soc Exp Biol Med. 1952;79:715–718. doi: 10.3181/00379727-79-19496. [DOI] [PubMed] [Google Scholar]
  • 34.Thicke JC, Duncan D, Wood W, Franklin AE, Rhodes AJ. Cultivation of poliomyelitis virus in tissue culture; growth of the Lansing strain in human embryonic tissues. Can J Med Sci. 1952;30:231–245. doi: 10.1139/cjms52-031. [DOI] [PubMed] [Google Scholar]
  • 35.Wood W, Franklin AE, Clark EM, Duncan D, Rhodes AJ. Cultivation of poliomyelitis virus in tissue culture; synthetic medium in roller tube cultures. Proc Soc Exp Biol Med. 1952;81:434–438. doi: 10.3181/00379727-81-19901. [DOI] [PubMed] [Google Scholar]
  • 36.Smith WM, Chambers VC, Evans CA. Growth of neurotropic viruses in extraneural tissues; preliminary report on the propagation of poliomyelitis virus (Lansing and Hof. strains) in cultures of human testicular tissue. Northwest Med. 1950;49:368–373. [PubMed] [Google Scholar]
  • 37.Smith WM, Chambers VC, Evans CA. Growth of neurotropic viruses in extraneural tissues; poliomyelitis virus in human testicular tissuein vitro. Proc Soc Exp Biol Med. 1951;76:696–700. doi: 10.3181/00379727-76-18598. [DOI] [PubMed] [Google Scholar]
  • 38.Salk JE. Studies in human subjects on active immunization against poliomyelitis; a preliminary report on experiments in progress. JAMA. 1953;151:1081–1098. [PubMed] [Google Scholar]
  • 39.Salk JE. Use of adjuvants in studies on influenza immunization; degree of persistence of antibody in human subjects two years after vaccination. JAMA. 1953;151:1169–1175. doi: 10.1001/jama.1953.02940140013005. [DOI] [PubMed] [Google Scholar]
  • 40.Eckardt RE, Director, Medical Research Division, Esso Laboratories, Linden, NJ. Personal communication; 1953.
  • 41.Twort CC, Twort JM. The carcinogenic potency of mineral oils. J Ind Hyg. 1931;13:204–226. [Google Scholar]
  • 42.Page RC, de Beer EJ. Production of cysts following intramuscular injection of vegetable oils. Am J Med Sci. 1943;205:812–814. doi: 10.1097/00000441-194306000-00009. [DOI] [Google Scholar]
  • 43.Ehrich WE, Halbert SP, Mertens E, Mudd S. Mechanism of the augmenting action of mineral oil on antibody production; tissue reactions and antibody response to dysentery vaccine in saline and in saline-lanolin-mineral-oil emulsion. J Exp Med. 1945;82:343–360. doi: 10.1084/jem.82.5.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hueper WC, Chief, Environmental Cancer Section, National Cancer Institute, Bethesda, Md. Personal communication; 1953.
  • 45.Pait CF, Pearson HE. Rabies vaccine encephalomyelitis in relation to the incidence of animal rabies in Los Angeles. Am J Public Health. 1949;39:875–877. doi: 10.2105/AJPH.39.7.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Remlinger P, Bailly J. Paralysies au cours du traitement antirabique chez le chien; application possible à Pétude des accidents paralytiques de l'homme. C R Soc Biol. 1927;96:772–773. [Google Scholar]
  • 47.Gey GO, Coffman WD, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium [abstract] Cancer Res. 1952;12:264–265. [Google Scholar]
  • 48.Li CP, Schaeffer M. Adaptation of Type 1 poliomyelitis virus to mice. Proc Soc Exp Biol Med. 1953;82:477–481. doi: 10.3181/00379727-82-20151. [DOI] [PubMed] [Google Scholar]
  • 49.Theiler M, Smith HH. The use of yellow fever virus modified byin vitro cultivation for human immunization. J Exp Med. 1937;65:787–800. doi: 10.1084/jem.65.6.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Theiler M, Smith HH. The effect of prolonged cultivationin vitro upon the pathogenicity of yellow fever virus. J Exp Med. 1937;65:767–786. doi: 10.1084/jem.65.6.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Theiler M. The Development of Vaccines Against Yellow Fever. Stockholm: Kungl. Boktryckeriet P.A. Norstedt and Söner; 1952. [Google Scholar]
  • 52.Cox HR. Use of yolk sac of developing chick embryo as medium for growing rickettsiae of Rocky Mountain spotted fever and typhus groups. Public Health Rep. 1938;53:2241–2247. doi: 10.2307/4582741. [DOI] [Google Scholar]
  • 53.Cox HR. A filter-passing infectious agent isolated from ticks; description of organism and cultivation experiments. Public Health Rep. 1938;53:2270–2276. doi: 10.2307/4582741. [DOI] [Google Scholar]
  • 54.Cox HR, Bell EJ. The cultivation of Rickettsia diaporica in tissue culture and in the tissues of developing chick embryos. Public Health Rep. 1939;54:2171–2178. doi: 10.2307/4583112. [DOI] [Google Scholar]
  • 55.Cox HR. Rocky Mountain spotted fever; protective value for guinea pigs of vaccine prepared from rickettsiae cultivated in embryonic chick tissues. Public Health Rep. 1939;54:1070–1077. doi: 10.2307/4582917. [DOI] [Google Scholar]
  • 56.Cox HR. Rickettsia diaporica and American Q fever. Am J Trop Med. 1940;20:463–469. doi: 10.4269/ajtmh.1940.s1-20.463. [DOI] [Google Scholar]
  • 57.Cox HR. Cultivation of rickettsiae of the Rocky Mountain spotted fever, typhus and Q fever groups in the embryonic tissues of developing chicks. Science. 1941;94:399–403. doi: 10.1126/science.94.2444.399. [DOI] [PubMed] [Google Scholar]
  • 58.Cox HR. Some recent advances and current problems in the field of rickettsial diseases. Arch Ges Virusforsch. 1951;4:518–533. doi: 10.1007/BF01241170. [DOI] [PubMed] [Google Scholar]
  • 59.Penna HA, Moussatché H. Modificação do virus de febre amarella por passagens em serie no embryão de gallinha em desenvolvimento. Brasilmed. 1939;53:903–904. [Google Scholar]
  • 60.Cox HR. Growth of viruses and rickettsiae in the developing chick embryo. Ann NY Acad Sci. 1952;55:236–247. doi: 10.1111/j.1749-6632.1952.tb26539.x. [DOI] [PubMed] [Google Scholar]
  • 61.Cox HR. Tissue cultures as a more sensitive method than animal inoculation for detecting equine encephalomyelitis virus. Proc Soc Exp Biol Med. 1936;33:607–609. doi: 10.3181/00379727-33-8468C. [DOI] [Google Scholar]
  • 62.Frenkel HS, Frederiks HHJ. Cultivation of foot-and-mouth disease virus in explanted epithelial tissue of the bovine rumen. Nature. 1949;164:235–236. doi: 10.1038/164235b0. [DOI] [PubMed] [Google Scholar]
  • 63.Frenkel HS. Histologic changes in explanted bovine epithelial tongue tissues infected with the virus of foot-and-mouth disease. Am J Vet Res. 1949;10:142–145. [PubMed] [Google Scholar]
  • 64.Frenkel HS, Dunne HW, Osteen OL. Foot-and-mouth disease virus propagation. J Am Vet Med Assoc. 1949;115:178–178. [Google Scholar]
  • 65.Frenkel HS. Research on foot-and-mouth disease; the cultivation of the virus on a practical scale in explantations of bovine tongue epithelium. Am J Vet Res. 1951;12:187–190. [PubMed] [Google Scholar]
  • 66.Frenkel HS, Dunne HW. Research on foot-and-mouth disease; cultivation of the foot-and-mouth disease virus in explanted epithelium of the bovine tongue; tissue and medium variations. Am J Vet Res. 1952;13:21–23. [PubMed] [Google Scholar]
  • 67.Boynton WH. Preliminary report on the propagation of hog cholera virusin vitro. Vet Med. 1946;41:346–347. [PubMed] [Google Scholar]
  • 68.Boynton WH, Takahashi WN, Woods GM, Walker WW. Further studies on propagation of hog cholera virusin vitro including electron micrographs. Vet Med. 1948;43:403–406. [PubMed] [Google Scholar]
  • 69.Clancy CF, Cox HR, Bottorff CA. Laboratory experiments with living Newcastle disease vaccine. Poult Sci. 1949;28:58–62. doi: 10.3382/ps.0280058. [DOI] [Google Scholar]
  • 70.Markham FS, Cox HR, Bottorff CA. Field trials with living virus vaccine for Newcastle disease. Poult Sci. 1949;28:52–57. doi: 10.3382/ps.0280052. [DOI] [Google Scholar]
  • 71.Markham FS, Bottorff CA, Tennison LB., Jr. Observations on the relationship of passive immunity to response following intranasal vaccination against Newcastle disease. Proc US Live Stock Sanit Assoc. 1950;54:161–165. [Google Scholar]
  • 72.Markham FS, Bottorff CA, Cox HR. The conjunctival application of Newcastle disease vaccine (intranasal type) in parentally immune and susceptible chicks. Cornell Vet. 1951;41:267–282. [PubMed] [Google Scholar]
  • 73.Cabasso V, Cox HR. Propagation of canine distemper virus on the chorio-allantoic membrane of embryonated hen eggs. Proc Soc Exp Biol Med. 1949;71:246–250. doi: 10.3181/00379727-71-17150. [DOI] [PubMed] [Google Scholar]
  • 74.Cabasso VJ, Burkhart RL, Leaming JD. The use of an egg-adapted modified canine distemper virus vaccine under experimental conditions and in the field. Vet Med. 1951;46:167–175. [PubMed] [Google Scholar]
  • 75.Cabasso VJ, Cox HR. A distemperlike strain of virus derived from a case of canine encephalitis; its adaptation to the chick embryo and subsequent modification. Cornell Vet. 1952;42:96–107. [PubMed] [Google Scholar]
  • 76.Cabasso VJ. Canine distemper and “hard pad” disease. Vet Med. 1952;47:417–423. [Google Scholar]
  • 77.Cabasso VJ. Canine viruses; distemper and “hard pad” disease, infectious canine hepatitis and rabies control. Southwest Vet. 1952–1953;6:19–24. [Google Scholar]
  • 78.Cabasso VJ, Stebbins MR, Cox HR. Onset of resistance and duration of immunity to distemper in ferrets following a single injection of avianized distemper vaccine. Vet Med. 1953;48:147–150. [Google Scholar]
  • 79.Koprowski H, James TR, Cox HR. Propagation of hog cholera virus in rabbits. Proc Soc Exp Biol Med. 1946;63:178–183. doi: 10.3181/00379727-63-15540. [DOI] [PubMed] [Google Scholar]
  • 80.Koprowski H, James TR, Cox HR. Laboratory studies and data on modified live hog cholera vaccine. Proc US Live Stock Sanit Assoc. 1951;55:214–223. [Google Scholar]
  • 81.Schroeder CR, Harvey MJ, Koprowski H, James TR, Cox HR. Trends in hog cholera immunization. Southwest Vet. 1952;5:217–223. [Google Scholar]
  • 82.Harvey MJ, Burkhart RL, Leaming JD, Percival RC, Schroeder CR, Welsh M. Field trial studies with Rovac. Proc US Live Stock Sanit Assoc. 1951;55:224–279. [Google Scholar]
  • 83.Gear J. Immunity to poliomyelitis. Ann Intern Med. 1952;37:1–22. doi: 10.7326/0003-4819-37-1-1. [DOI] [PubMed] [Google Scholar]
  • 84.Kolmer JS, Rule AM. Concerning vaccination of monkeys against acute anterior poliomyelitis with special reference to oral immunization. J Immunol. 1934;26:505–515. [Google Scholar]
  • 85.Koprowski H, Jervis GA, Norton TW. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am J Hyg. 1952;55:108–126. doi: 10.1093/oxfordjournals.aje.a119499. [DOI] [PubMed] [Google Scholar]
  • 86.Koprowski H, Jervis GA, Norton TW, Nelsen DJ. Further studies on oral administration of living poliomyelitis virus to human subjects. Proc Soc Exp Biol Med. 1953;82:277–280. doi: 10.3181/00379727-82-20091. [DOI] [PubMed] [Google Scholar]
  • 87.Roca-Garcia M, Moyer AW, Cox HR. Poliomyelitis; propagation of MEF1 strain of poliomyelitis virus in developing chick embryo by yolk sac inoculation. Proc Soc Exp Biol Med. 1952;81:519–525. doi: 10.3181/00379727-81-19928. [DOI] [PubMed] [Google Scholar]
  • 88.Cabasso VJ, Stebbins MR, Dutcher RM, Moyer AW, Cox HR. Poliomyelitis; propagation of MEF1 strain of poliomyelitis virus in developing chick embryo by allantoic cavity inoculation. Proc Soc Exp Biol Med. 1952;81:525–529. doi: 10.3181/00379727-81-19929. [DOI] [PubMed] [Google Scholar]
  • 89.Moyer AW, Accorti C, Cox HR. Poliomyelitis; propagation of the MEF1 strain of poliomyelitis virus in the suckling hamster. Proc Soc Exp Biol Med. 1952;81:513–518. doi: 10.3181/00379727-81-19927. [DOI] [PubMed] [Google Scholar]
  • 90.Roca-Garcia M. et al. Unpublished data.
  • 91.Cabasso VJ. et al. Unpublished data.
  • 92.Burruss H. US government technical consultant on yellow fever vaccine, National Drug Co., Swiftwater, Pa. Personal communication; 1953.

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES